Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
about
Emerging roles for the non-canonical IKKs in cancerβ-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesisIdentification of PP2A complexes and pathways involved in cell transformationSIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasisPME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant gliomaGenomic screening with RNAi: results and challengesExpression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomasThe NF-κB Pathway and Cancer Stem CellsSteroid Receptor-Associated Immunophilins: A Gateway to Steroid SignallingAkt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytesGenome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like CellsHuman Cyclin-dependent Kinase 2-associated Protein 1 (CDK2AP1) Is Dimeric in Its Disulfide-reduced State, with Natively Disordered N-terminal RegionNarrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesCopper is required for oncogenic BRAF signalling and tumorigenesisPAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingPI3K-independent AKT activation in cancers: a treasure trove for novel therapeuticsSmall-molecule inhibitors of IκB kinase (IKK) and IKK-related kinasesDevelopment of a high-throughput assay for identifying inhibitors of TBK1 and IKKεMEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of AutophagyDeciphering fact from artifact when using reporter assays to investigate the roles of host factors on L1 retrotranspositionExosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction moduleThe landscape of somatic copy-number alteration across human cancers.COT drives resistance to RAF inhibition through MAP kinase pathway reactivationSystematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Inflammation meets cancer, with NF-κB as the matchmakerTNF-insulin crosstalk at the transcription factor GATA6 is revealed by a model that links signaling and transcriptomic data tensors.A high-throughput assay for phosphoprotein-specific phosphatase activity in cellular extracts.An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection.Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survivalTargeting pathways downstream of KRAS in lung adenocarcinoma.WIPI3 and WIPI4 β-propellers are scaffolds for LKB1-AMPK-TSC signalling circuits in the control of autophagy.Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.Towards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging.Biology-driven cancer drug development: back to the futurePPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signalingCK1epsilon is required for breast cancers dependent on beta-catenin activity.PTK6 regulates IGF-1-induced anchorage-independent survival.IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.
P2860
Q24305225-C3AB2ED0-9A04-45A4-A126-CF115E354E1DQ24306274-7D06BF70-4DE9-4E05-BFE6-F5DB7932175EQ24316472-0C64E704-F91B-4F1C-A269-E0E03B6EC7E2Q24316768-E61FAD97-A377-450E-ACCB-566A42D64C58Q24322118-77E4244C-67F4-43FD-8191-77657011779FQ24626537-FB64D480-2B8D-4BB6-83BE-31D8245BC88AQ24657474-5B62B7AA-36BE-480C-BF54-F9D37B25743BQ26750605-FA78984E-57B2-40C0-BEA4-B75592FE5687Q26801686-C0736C56-3D26-4866-B0E2-4C759280BE9BQ27318498-1BF0C9EE-D602-4BFA-AC57-8B4F27ACDC58Q27320024-AA5B7EE0-F274-412C-902D-44A3D8A13A30Q27678086-1E8CD408-AAD3-4004-9946-D289CE232AF1Q28072745-DACD1BCA-1793-4C76-9548-E27940F9B499Q28237892-397A6004-4514-4577-81EB-CF4245ED632DQ28253621-8ACAD44F-33B2-48FC-9D66-F19A562D7A3DQ28259003-178E1CDF-0980-4A11-96E5-B834EA3081BCQ28302027-DF298BE4-BE1C-4DBF-A103-96DD872EC469Q28481686-5D22C4D9-21D6-4C71-91F3-22579FE7A876Q28552218-984C6DC3-CCE5-4E0C-932C-4B320C037192Q28593628-6770B5AB-F843-4FBD-8C12-993EDEA9D806Q28828801-12AE8D53-1416-43DE-89FA-494FAA8FF586Q29547648-E048F3E7-98E9-44DD-B09B-1EF6F980AEF0Q29615032-297C87CD-F764-40C5-84F6-EC29118F4B81Q29617043-C0446F1D-7CFD-4F7A-98EF-C2FD24EC0C8AQ29620242-B87F8A56-A80D-4C0D-9F8D-A8A1B1A045E3Q30276641-20A3F435-4615-4C35-BAA5-FECF0573FE48Q30414621-2D81DDC0-0AFF-466F-BE7A-61E2B94663F9Q30415276-9385B3C0-BEAA-448D-92CC-EB275DB45CF5Q30452448-57E33E00-BF11-4628-8641-496052301B4EQ30495169-D65B698A-B5A5-4AFF-96D1-4BFB0730CD1FQ30597330-6C0B9537-5331-479D-8E65-0F43EC541B72Q30854841-ADEA60C0-2083-493E-A3A5-1E88E33A9BE5Q33456429-808CF7FD-E062-4477-9DB5-DDC7C5C50D5DQ33459037-544A8AFF-9D21-418D-A332-9C30C51CA104Q33552888-F789F0C1-E153-4248-8481-DDEEA0C2965BQ33594693-AE4E3239-815C-4B6E-81CA-12587C987125Q33620584-3EFBB9EE-18BD-4994-9752-BA6580542CDDQ33644326-527A04D7-8FF5-4DBC-A3D3-44D5945CC9A1Q33662031-F723FAD3-4248-428D-9C3B-2036DCCD361FQ33717414-D7D7850E-D2BA-4A09-B9AE-977A4A4E2B1B
P2860
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@ast
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@en
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@nl
type
label
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@ast
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@en
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@nl
altLabel
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
@en
prefLabel
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@ast
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@en
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@nl
P2093
P50
P1433
P1476
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
@en
P2093
Andrea L Richardson
Carly J Stewart
David E Hill
David E Root
Greg Hinkle
Ian F Dunn
Jean J Zhao
Jennifer K Grenier
Kornelia Polyak
P304
P356
10.1016/J.CELL.2007.03.052
P407
P577
2007-06-01T00:00:00Z